
RevOpsis Therapeutics Receives Strategic Investment from ExSight Ventures
RevOpsis Therapeutics, a biopharmaceutical company pioneering multispecific biologics for vision loss, has received a strategic investment from ExSight Ventures, a venture capital firm dedicated to investing in transformative ophthalmology innovations. While the amount of the investment was not disclosed, the…


















